Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yong Chen
Observed names:
Chen, Y.,
Y CHEN
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
The Affiliated Yongchuan Hospital of Chongqing Medical University,
Northern Jiangsu People's Hospital
ORCID:
0000-0003-2297-8985
Observed ORCID:
0000-0003-2297-8985
OpenAlex ID:
A5100454453
BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies
2022
·
Jingqin Zhong
, Wangjun Yan
, et al.
·
Current Treatment Options in Oncology
·
102
PDF
USP21 promotes cell proliferation and metastasis through suppressing EZH2 ubiquitination in bladder carcinoma
2017
·
Yong Chen
, Bo Zhou
, et al.
·
OncoTargets and Therapy
·
64
PDF
Adenosine A2b receptor is highly expressed in human hepatocellular carcinoma
2006
·
H XIANG
, Z LIU
, et al.
·
Hepatology Research
·
37
Metabolism of Reactive Oxygen Species in Osteosarcoma and Potential Treatment Applications
2019
·
Wei Sun
, Bing Wang
, et al.
·
Cells
·
35
PDF
Inhibitor of DNA binding proteins: implications in human cancer progression and metastasis.
2018
·
Jing Ke
, Ruolin Wu
, et al.
·
Europe PMC (PubMed Central)
·
34
Overcoming treatment resistance in cholangiocarcinoma: current strategies, challenges, and prospects
2024
·
Jiayi Wang
, Siyan Liu
, et al.
·
Frontiers in Cell and Developmental Biology
·
24
Identification of the potential prognostic genes of human melanoma
2018
·
Bing Wang
, Xing‐Long Qu
, et al.
·
Journal of Cellular Physiology
·
21
BRAF, C-KIT, and NRAS mutations correlated with different clinicopathological features: an analysis of 691 melanoma patients from a single center
2021
·
Min Ren
, Jing Zhang
, et al.
·
Annals of Translational Medicine
·
16
PDF
PD‐1 blockade treatment in melanoma: Mechanism of response and tumor‐intrinsic resistance
2024
·
Tong Wang
, Wenjie Ma
, et al.
·
Cancer Science
·
10
PDF
Gene Fusions as Potential Therapeutic Targets in Soft Tissue Sarcomas
2025
·
Qiongdan Zheng
, Tong Wang
, et al.
·
Biomolecules
·
5
PDF
Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies
2022
·
Jingqin Zhong
, Wangjun Yan
, et al.
·
Current Treatment Options in Oncology
·
3
PDF
Oncogenic alterations reveal key strategies for precision oncology in melanoma treatment
2022
·
Wei Sun
, Fang Zhao
, et al.
·
Annals of Translational Medicine
·
1
A real-world study of recombinant human endostatin continuous intravenous infusion combined with chemotherapy in the treatment of advanced mucosal melanoma.
2019
·
Xin Liu
, Jun Cao
, et al.
·
Journal of Clinical Oncology
·
1
A retrospective study of anti-PD-1 combined with temozolomide adjuvant therapy for stage III resected acral melanoma
2025
·
Wenjie Ma
, Guodong Luo
, et al.
·
Research Square
PDF
IGF2BP3 Promotes Lung Cancer Progression Through FTO Dependent m6A Modification by Stabilizing N-myc
2021
·
Xiaolin Wang
, Yong Chen
, et al.
·
SSRN Electronic Journal
Ulixertinib. Extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitor, Treatment of cancers with RAS-ERK aberrant activation
2021
·
Ji, N.
, Yang, Y.
, et al.
·
Drugs of the Future
Oncogenic Alterations Reveal Key Strategies for Precision Oncology in Melanoma Treatment
2021
·
Wei Sun
, Fang Zhao
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
17
Citation count:
351
H-index:
9
I10-index:
9
Year
Topic
Type